JP2017515872A5 - - Google Patents

Download PDF

Info

Publication number
JP2017515872A5
JP2017515872A5 JP2016568523A JP2016568523A JP2017515872A5 JP 2017515872 A5 JP2017515872 A5 JP 2017515872A5 JP 2016568523 A JP2016568523 A JP 2016568523A JP 2016568523 A JP2016568523 A JP 2016568523A JP 2017515872 A5 JP2017515872 A5 JP 2017515872A5
Authority
JP
Japan
Prior art keywords
layer
phase
therapeutic system
transdermal therapeutic
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016568523A
Other languages
English (en)
Japanese (ja)
Other versions
JP6599899B2 (ja
JP2017515872A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/061112 external-priority patent/WO2015177212A1/en
Publication of JP2017515872A publication Critical patent/JP2017515872A/ja
Publication of JP2017515872A5 publication Critical patent/JP2017515872A5/ja
Application granted granted Critical
Publication of JP6599899B2 publication Critical patent/JP6599899B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016568523A 2014-05-20 2015-05-20 界面介在物を含む経皮送達システム Active JP6599899B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14169031 2014-05-20
EP14169031.3 2014-05-20
PCT/EP2015/061112 WO2015177212A1 (en) 2014-05-20 2015-05-20 Transdermal delivery system including an interface mediator

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019181803A Division JP6820391B2 (ja) 2014-05-20 2019-10-02 界面介在物を含む経皮送達システム

Publications (3)

Publication Number Publication Date
JP2017515872A JP2017515872A (ja) 2017-06-15
JP2017515872A5 true JP2017515872A5 (cg-RX-API-DMAC7.html) 2018-06-21
JP6599899B2 JP6599899B2 (ja) 2019-10-30

Family

ID=50735940

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568523A Active JP6599899B2 (ja) 2014-05-20 2015-05-20 界面介在物を含む経皮送達システム
JP2019181803A Active JP6820391B2 (ja) 2014-05-20 2019-10-02 界面介在物を含む経皮送達システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019181803A Active JP6820391B2 (ja) 2014-05-20 2019-10-02 界面介在物を含む経皮送達システム

Country Status (7)

Country Link
US (2) US11752110B2 (cg-RX-API-DMAC7.html)
EP (2) EP4238580A3 (cg-RX-API-DMAC7.html)
JP (2) JP6599899B2 (cg-RX-API-DMAC7.html)
CN (1) CN106456568B (cg-RX-API-DMAC7.html)
CA (1) CA2948221C (cg-RX-API-DMAC7.html)
ES (1) ES2954087T3 (cg-RX-API-DMAC7.html)
WO (1) WO2015177212A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017073516A1 (ja) * 2015-10-26 2017-05-04 久光製薬株式会社 貼付剤
WO2018115001A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
RU2764443C2 (ru) 2016-12-20 2022-01-17 Лтс Ломанн Терапи-Систем Аг Трансдермальная терапевтическая система, содержащая азенапин и полисилоксан или полиизобутилен
CN110799180A (zh) 2017-06-26 2020-02-14 罗曼治疗系统股份公司 含阿塞那平和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
AU2019291060B2 (en) 2018-06-20 2024-09-05 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
KR102710072B1 (ko) * 2018-08-31 2024-09-24 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
JP7399633B2 (ja) * 2019-06-14 2023-12-18 株式会社大石膏盛堂 経皮吸収型製剤の製造方法
AU2021391823A1 (en) 2020-12-03 2023-06-29 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
IL307454A (en) 2021-04-07 2023-12-01 Battelle Memorial Institute Technologies for rapid design, construction, testing, learning to identify and use non-viral vectors
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en) 2023-12-08 2025-06-12 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US5719197A (en) 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5300291A (en) 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US4814168A (en) 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
US4994267A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5032207A (en) 1988-03-04 1991-07-16 Noven Pharmaceuticals, Inc. One-step method for forming a pressure-sensitive adhesive transdermal drug device
US4994278A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Breathable backing
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5405486A (en) 1988-03-04 1995-04-11 Noven Pharmaceuticals, Inc. Apparatus for forming a transdermal drug device
DE69029909T2 (de) 1990-03-28 1997-09-11 Noven Pharma Verfahren und vorrichtung zur freisetzung von arzneimittel an die haut
AU2004092A (en) 1991-04-25 1992-12-21 Noven Pharmaceuticals, Inc. Method and apparatus for forming a transdermal drug device
US5387189A (en) 1993-12-02 1995-02-07 Alza Corporation Electrotransport delivery device and method of making same
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6757560B1 (en) 1999-04-09 2004-06-29 Novosis Pharma Ag Transdermal delivery system (TDS) with electrode network
US7655249B2 (en) 1998-09-30 2010-02-02 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US6317630B1 (en) 1999-01-29 2001-11-13 Yossi Gross Drug delivery device
ES2260021T3 (es) 1999-06-08 2006-11-01 Altea Therapeutics Corporation Aparatos para la microporacion de membranas biologicas utilizando dispositivos de interfaz de tejido de pelicula delgada, y su metodo.
RU2263502C2 (ru) 1999-07-02 2005-11-10 Лтс Ломанн Терапи-Системе Аг Микрорезервуарная система на основе полисилоксанов и амбифильных растворителей
DE10012908B4 (de) 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10041479A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
SK12032003A3 (sk) 2001-04-02 2004-03-02 Astrazeneca Ab Farmaceutická formulácia obsahujúca 4'-kyano-alfa', alfa', alfa'-trifluór-3-(4-fluórfenylsulfonyl)-2-hydroxy-2- metylpropiono-m-toluidín a PVP
DE10118282A1 (de) 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
PT1256339E (pt) 2001-05-08 2004-02-27 Lohmann Therapie Syst Lts Sistema terapeutico transdermico para doenca de parkinson que induz niveis plasmaticos altos de rotigotina
US20030026830A1 (en) 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
ES2203563T3 (es) 2001-05-08 2004-04-16 Schwarz Pharma Ag Sistema terapeutico transdermico mejorado para el tratamiento de la enfermedad de parkinson.
DE10141651B4 (de) 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
AU2002329763B2 (en) * 2001-08-17 2007-11-08 Lavipharm Laboratories Inc. Composition and transdermal drug delivery device
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
US6775570B2 (en) 2002-02-04 2004-08-10 Ceramatec, Inc. Iontophoretic treatment device
US20030180281A1 (en) 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
US20060263419A1 (en) 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
DE10220230A1 (de) 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
EP1386605A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine
EP1386604A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
US8211462B2 (en) 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
DK1426049T3 (da) 2002-12-02 2005-08-22 Sanol Arznei Schwarz Gmbh Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US7603144B2 (en) 2003-01-02 2009-10-13 Cymbet Corporation Active wireless tagging system on peel and stick substrate
JP2006515952A (ja) 2003-01-02 2006-06-08 シンベット・コーポレイション ソリッドステートのバッテリー給電の装置と製法
NZ541956A (en) 2003-04-14 2008-09-26 Lohmann Therapie Syst Lts Therapeutic patch with polysiloxane matrix comprising capsaicin
EP1663179A1 (en) 2003-07-21 2006-06-07 Noven Pharmaceuticals, Inc. Composition and method for controlling drug delivery from silicone adhesive blends
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
EP1547592A1 (en) 2003-12-23 2005-06-29 Schwarz Pharma Ag Intranasal formulation of rotigotine
DE10361259A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
JP5186208B2 (ja) 2004-05-28 2013-04-17 ジェート、ジャン ドゥ 確認装置および確認システム
JP2006178807A (ja) 2004-12-24 2006-07-06 Echigo Fudagami Kk Ｉｃシート製造装置及びｉｃシート製造方法
GB0506139D0 (en) 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
DE102006054733A1 (de) 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
CN101147739B (zh) 2007-07-06 2010-12-08 北京康倍得医药技术开发有限公司 含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
JP2010536434A (ja) 2007-08-17 2010-12-02 イシス バイオポリマー エルエルシー イオン泳動薬物送達システム
US20100311661A1 (en) 2007-08-24 2010-12-09 Max Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
AR068916A1 (es) 2007-10-19 2009-12-16 Abbott Gmbh & Co Kg Producto de dispersion solida que contiene un compuesto a base de n- aril urea
ME02275B (me) 2007-11-28 2016-02-20 Ucb Pharma Gmbh Polimorfni oblik rotigotina
US20110182949A1 (en) * 2008-05-30 2011-07-28 Jiashang Tang Stabilized transdermal drug delivery system
JP2009297808A (ja) 2008-06-11 2009-12-24 Chiyoda Integre Co Ltd 粘着テープ製造方法及び粘着テープ製造装置
EP2140861A1 (en) 2008-06-30 2010-01-06 Abbott GmbH & Co. KG Pharmaceutical dosage form comprising polymeric carrier composition
AR074047A1 (es) 2008-09-09 2010-12-22 Transcu Ltd Sistemas, dispositivos, y metodos para suministrar energia a dispositivos, por ejemplo dispositivos de administracion transdermica y/o para controlarlos
CA2739380C (en) 2008-10-06 2014-12-09 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
US20100286590A1 (en) 2009-05-08 2010-11-11 Isis Biopolymer Llc Iontophoretic device with improved counterelectrode
EP2281559A1 (en) 2009-06-26 2011-02-09 UCB Pharma GmbH Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
MX2012007326A (es) * 2009-12-22 2012-08-01 Lohmann Therapie Syst Lts Polivinilpirrolidona para la estabilizacion de una dispersion solida de forma no cristalina de rotigotina.
MX336812B (es) 2010-11-23 2016-02-02 Teva Pharmaceuticals Int Gmbh Sistema de suministro de farmaco iontoforetico co - empacado auto - contenido activado por el usuario.
WO2012084969A1 (en) * 2010-12-22 2012-06-28 Hexal Ag Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
DE102012013421A1 (de) 2012-07-03 2014-01-09 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System (TTS) mit Rotigotin
WO2013075823A1 (en) 2011-11-22 2013-05-30 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermal therapeutic system comprising rotigotine and crystallization inhibitor
SG10201604754VA (en) * 2011-12-12 2016-08-30 Lohmann Therapie Syst Lts Transdermal delivery system comprising buprenorphine
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
PT2810646T (pt) * 2013-06-04 2016-10-05 Lts Lohmann Therapie Systeme Ag Sistema de administração transdérmica

Similar Documents

Publication Publication Date Title
JP2017515872A5 (cg-RX-API-DMAC7.html)
JP2017515869A5 (cg-RX-API-DMAC7.html)
RU2670750C2 (ru) Композиции для местного применения и способы лечения локальных нарушений
EA201500553A1 (ru) Многодневный пластырь для чрескожного введения ротиготина
CN106456566B (zh) 含罗替戈汀的经皮递送系统
JP5542665B2 (ja) マトリックス型経皮投与剤およびその製造方法
JP2016520638A5 (cg-RX-API-DMAC7.html)
JP2020019788A (ja) 界面介在物を含む経皮送達システム
JPS6214526B2 (cg-RX-API-DMAC7.html)
JP2002531488A5 (cg-RX-API-DMAC7.html)
EP3160461A1 (en) Transdermal delivery system
JP2016504368A5 (cg-RX-API-DMAC7.html)
WO2011050728A1 (zh) 一种稳定的雷沙吉兰组合物
CN101146524A (zh) 经皮局部用组合物及其应用
MXPA05005510A (es) Administracion dermica de un inhibidor selectivo de la ciclooxigenasa-2, soluble en agua, por ejemplo, parecoxib y valdecoxib.
TW200902090A (en) Transdermal administration device for bisoprolol
CA2275769A1 (en) Extremely flexible plaster acting dermally or transdermally, and method for producing same
WO2017146096A1 (ja) 貼付剤
JPH04234322A (ja) ピリベジールの持続的経皮放出のための自己粘着性マトリックス系
US20130281542A1 (en) Selegiline transdermal system
JP2020505422A5 (cg-RX-API-DMAC7.html)
WO2008103852A1 (en) Transdermal delivery of dexamethasone and promethazine
JP7063537B2 (ja) ラベンダー油を含有する経皮治療システム
Singh et al. A Brief Review on Transdermal Patches
JP2006045099A (ja) 経皮吸収貼付剤